NEXPOVIO 20 mg, film-coated tablet 16 tablets
Active ingredients: Selinexor
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet16 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NEXPOVIO 20 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 16 comprimés conditionnés en 4 plaquettes PVC polychlortrifluoroéthylène PVC-Aluminium de 4 comprimés suremballées avec fermeture de sécurité enfant
- Marketing authorisation holder
- STEMLINE THERAPEUTICS (PAYS-BAS)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Oct 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
64317942CIP73025801CIP133400930258019Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SÉLINEXORcomprimé | 20 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.